Abstract Submission

On behalf of the Scientific Committee of the ISAD 2019, thank you for submitting your work for presentation at the 10th Conference of the International Society for Affective Disorders in London, United Kingdom. We have an on-line submission and evaluation process administered by Kenes; please take a moment to read the following simple guidelines.

All abstracts must be submitted on-line through the abstract submission system. Abstracts that are sent via e-mail or fax will not be included in the abstract assessment process by the Scientific Committee.

Abstract submission deadline is April 10th, 2019.

Kindly note that the abstract submission system will be closed after this deadline.

buton

Abstract Submission Guideline

  • The submitting author assumes full responsibility for the contents of the abstract and must ensure that all other authors have approved the abstract before submission.
  • The submitting author will be required to register for the congress in order to have acceptance of the abstract confirmed and submitted for publication in the journal's proceedings.

Preparation of Abstracts:

  • All abstracts must be submitted in English.
  • Category: A main category (see below) that is relevant for your abstract must be selected during the submission process. The Scientific Committee reserves the right to change the category during the abstract assessment process.
  • Presentation type: Symposium

Each symposium will be allocated a total of 90 minutes.
Each symposium will have a maximum of four presenters

The Scientific Committee reserves the right to change the presentation type according to the requirements of the scientific programme
Title: Abstract title can contain a maximum of 250 characters.

  • Author(s): First and last names, institutions, and e-mail addresses of the authors must be fully indicated correctly and in the right order.
  • Institution(s): The institution(s) of the authors should be indicated fully with the "department" and "institution" names while avoiding any abbreviations such as Dept., Inst., Hosp., etc. The institution and city should be written in lower case while the initials of each word are written in capitals
  • Abstract text: Abstract text should not exceed 300 words. The title of the abstract, authors' names, institutions and key words are not included in this limit.
  • Images, tables, diagrams and graphs are allowed for the abstracts.
  • Keywords: Keywords should not be included in any of the sections of the abstract text, and written only in the section dedicated for keywords. A maximum 5 keywords can be provided. All keywords should be written in lower case (e.g.: hydrocephalus).
  • Please do not submit multiple copies of the same abstract.

Please get in contact with Ms. Neyir Seda Utugen from the Congress Secretariat (nutugen@kenes.com) for editing after submitting the abstract. 

Please ensure that the e-mail address of abstract authors are entered correctly to enable the Congress Organizing Secretariat to communicate with you regarding the abstract. All information regarding the acceptance, any required adjustments, and scheduling will be communicated via e-mail to the abstract presenting author.

The abstract categories will be as follows:

  • Psychiatric/medical comorbidity in mood & anxiety disorders
  • Innovative psychopharmacology
  • (neuro-)inflammation in mood & anxiety disorders
  • Autoimmune disorders
  • Gut and microbiome in mood & anxiety disorders
  • Mobile technology/Big Data in mood & anxiety disorders
  • Sleep-wake cycle/circadian rhythm disturbances in mood & anxiety disorders
  • Integration of biological and psychological treatments in mood & anxiety disorders
  • Cultural and gender variations in mood & anxiety disorders 
  • Genetic and pharmacogenetic approaches to mood & anxiety disorders 
  • Brain stimulation approaches for mood & anxiety disorders 
  • Brain structure and function in mood & anxiety disorders
  • Service development for mood & anxiety disorders
  • Pre-onset identification of mood & anxiety disorders
  • Mood and anxiety disorders in children and adolescents 
  • Measurement challenges; innovative research designs in mood & anxiety disorders
  • Epigenetics, prenatal exposure to stress and mood & anxiety disorders
  • Psycho-education, self-help, information and communication technologies
  • Mood and anxiety disorders in the elderly
  • Biomarkers for mood & anxiety disorders
  • Suicide in mood & anxiety disorders

Evaluation Process and Acceptance Letters:
All submitted abstracts will be scored by members of the Scientific Committee following which the draft program will be drawn up.

Acceptance letters will be sent via e-mail. Relevant information about your abstract's presentation including the presentation date, time, venue, presentation number will be included in the acceptance letters. 

Thank you for submitting your work for consideration. We are looking forward to meeting you for what promises to be a fabulous meeting in London! Please make contact with us directly should you have any specific enquiries.

Scientific Committee Chair

Kenes M+, Scientific Programme Coordinator
Neyir Seda Utugen, nutugen@kenes.com

On behalf of the Scientific Committee of the ISAD 2019, thank you for submitting your work for presentation at the 10th Conference of the International Society for Affective Disorders in London, United Kingdom. We have an on-line submission and evaluation process administered by Kenes; please take a moment to read the following simple guidelines.

All abstracts must be submitted on-line through the abstract submission system. Abstracts that are sent via e-mail or fax will not be included in the abstract assessment process by the Scientific Committee.

Abstract submission deadline is May 24, 2019.

Kindly note that the abstract submission system will be closed after this deadline.

buton

Abstract Submission Guideline

  • The presenting author assumes full responsibility for the contents of the abstract and must ensure that all other authors have approved the abstract before submission.
  • The presenting author will be required to register for the congress in order to have acceptance of the abstract confirmed and submitted for publication in the journal's proceedings.

Preparation of Abstracts:

  • All abstracts must be submitted in English.
  • Category: A main category (see below) that is relevant for your abstract must be selected during the submission process. The Scientific Committee reserves the right to change the category during the abstract assessment process.
  • Presentation type: As usual, abstracts will be considered either for:

       - Oral Presentation
       - Poster Presentation


Your preference (oral or poster) should be indicated during the submission process. The Scientific Committee reserves the right to change the presentation type according to the requirements of the scientific programme

Title: Abstract title can contain a maximum of 250 characters.

  • Author(s): First and last names, institutions, and e-mail addresses of the authors must be fully indicated correctly and in the right order.
  • Institution(s): The institution(s) of the authors should be indicated fully with the "department" and "institution" names while avoiding any abbreviations such as Dept., Inst., Hosp., etc. The institution and city should be written in lower case while the initials of each word are written in capitals
  • Abstract text: Abstract text should not exceed 300 words. The title of the abstract, authors' names, institutions and key words are not included in this limit.

       The abstract should have four sections:
       - Objective
       - Material and Methods
       - Results
       - Conclusion

  • Images, tables, diagrams and graphs are allowed/ are not allowed for the abstracts.
  • Keywords: Keywords should not be included in any of the sections of the abstract text, and written only in the section dedicated for keywords. A maximum 5 keywords can be provided. All keywords should be written in lower case (e.g.: hydrocephalus).
  • Please do not submit multiple copies of the same abstract.

Please get in contact with Ms. Neyir Seda Utugen from the Congress Secretariat (nutugen@kenes.com) for editing after submitting the abstract. 

Please ensure that the e-mail address of abstract authors are entered correctly to enable the Congress Organizing Secretariat to communicate with you regarding the abstract. All information regarding the acceptance, any required adjustments, and scheduling will be communicated via e-mail to the abstract presenting author.

The abstract categories will be as follows:

  • Psychiatric/medical comorbidity in mood & anxiety disorders
  • Innovative psychopharmacology
  • (neuro-)inflammation in mood & anxiety disorders
  • Autoimmune disorders
  • Gut and microbiome in mood & anxiety disorders
  • Mobile technology/Big Data in mood & anxiety disorders
  • Sleep-wake cycle/circadian rhythm disturbances in mood & anxiety disorders
  • Integration of biological and psychological treatments in mood & anxiety disorders
  • Cultural and gender variations in mood & anxiety disorders 
  • Genetic and pharmacogenetic approaches to mood & anxiety disorders 
  • Brain stimulation approaches for mood & anxiety disorders 
  • Brain structure and function in mood & anxiety disorders
  • Service development for mood & anxiety disorders
  • Pre-onset identification of mood & anxiety disorders
  • Mood and anxiety disorders in children and adolescents 
  • Measurement challenges; innovative research designs in mood & anxiety disorders
  • Epigenetics, prenatal exposure to stress and mood & anxiety disorders
  • Psycho-education, self-help, information and communication technologies
  • Mood and anxiety disorders in the elderly
  • Biomarkers for mood & anxiety disorders
  • Suicide in mood & anxiety disorders

Evaluation Process and Acceptance Letters:
All submitted abstracts will be scored by 3-4 members of the Scientific Committee following which the draft program will be drawn up.

Acceptance letters will be sent via e-mail. Relevant information about your abstract's presentation including the presentation date, time, venue, presentation number will be included in the acceptance letters. 

Thank you for submitting your work for consideration. We are looking forward to meeting you for what promises to be a fabulous meeting in London! Please make contact with us directly should you have any specific enquiries.

Scientific Committee Chair

Kenes M+, Scientific Programme Coordinator
Neyir Seda Utugen,  nutugen@kenes.com